Patients with primary sclerosing cholangitis (PSC) who are found to have gallbladder polyps exceeding 8 mm in diameter represent a distinct clinical subgroup with specific management implications.
In this setting, a surgical approach is the central component of management. The complete clinical decision pathway — including full eligibility criteria and sequencing — is available in the structured evidence-based protocol.
DOI: 10.1038/ajg.2015.112
Cholecystectomy should be performed for patients with PSC and gallbladder polyps >8 mm, to prevent the development of gallbladder adenocarcinoma.
View source ↗